Andrew Goldberg Sells TARS Shares

Andrew Goldberg sold 2,954 shares of TARS on June 12, 2026.

Written by EarningsIQ · Published Jun 16, 2026, 5:03 PM EDT

Key Points

Andrew Goldberg sold 2,954 shares of TARS on June 12, 2026, without a planned transaction code.
TARS shares recently traded at $61.85, with peers like Deep Track Capital and BlackRock adjusting their holdings.
Analysts from HC Wainwright & Co. and Oppenheimer maintain a 'buy' rating, with price targets of $88 and $105 respectively.

Andrew Goldberg sold 2,954 shares of TARS on June 12, 2026. The transaction wasn't part of a pre-planned trading arrangement, often referred to as a Rule 10b5-1 plan. While the sale was recorded, the exact value of the transaction wasn't disclosed.

Other Institutional Activity in TARS

In recent movements among institutional investors, Deep Track Capital grew its holdings in TARS by 595,966 shares, bringing its total to 3.6 million shares valued at about $252.54 million. BlackRock, Inc. reduced its position by 237,945 shares, now holding 3,552,612 shares worth around $249.22 million. RTW Investments, LP made a modest increase of 10,705 shares, ending with 3,346,025 shares valued at approximately $234.72 million. Meanwhile, Paradigm Biocapital Advisors LP maintained its position with 2,562,154 shares valued at $179.74 million. Janus Henderson Group PLC increased its stake by 310,638 shares, totaling 2,240,963 shares valued at around $157.22 million.

TARS Stock Snapshot

TARS shares recently traded at $61.85. The company has been a point of interest for several institutional investors adjusting their holdings. The stock's performance and valuation continue to attract attention from both institutional investors and analysts.

Insider Buying and Selling at TARS

Alongside Andrew Goldberg's sale, several other insiders were active on June 12, 2026. Bhaskar Chaudhuri sold 2,954 shares, while Wendy Yarno both bought and sold 2,954 shares. William Link also bought 2,954 shares, and Scott Morrison sold the same amount. None of these transactions were part of a planned trading program.

Analysts Set New Price Targets

On May 4, 2026, HC Wainwright & Co. reiterated a 'buy' rating for TARS with a price target of $88. Earlier in the year, on February 25, 2026, Oppenheimer maintained its 'buy' rating with a higher target of $105. Guggenheim also maintained its 'buy' rating with a target of $90.

Bottom Line

Andrew Goldberg's recent sale of TARS shares is one of several insider transactions that have occurred. Institutional investors like Deep Track Capital and BlackRock have also been adjusting their positions, reflecting varied strategies. Analysts maintain positive outlooks with 'buy' ratings, suggesting continued interest in TARS. Note that insider transactions and institutional holdings are backward-looking and may not reflect current positions.